The realm of medical devices is on a transformative path, markedly influenced by the integration of advanced materials like Nitinol. Known for its remarkable superelasticity, shape memory effect, and superior damping characteristics, Nitinol stands as a cornerstone in the development of innovative
Recce Pharmaceuticals, a Sydney-based biotechnology company, has successfully raised A$15.8 million to advance its groundbreaking anti-infective drugs into Phase 3 trials. This funding was obtained through a combination of private placement and an entitlement offer. Recce's synthetic
The medical and life sciences manufacturing sector is experiencing rapid transformations, bringing forth a plethora of challenges and opportunities for industry professionals. Ascential's "2025 State of Medical & Life Sciences Manufacturing" report delves into key areas such as
The biopharmaceutical sector has witnessed significant changes in leadership roles within major Contract Development and Manufacturing Organizations (CDMOs), driving strategic growth and development. The appointment of seasoned leaders plays a crucial role in strengthening the research,
The global bioinformatics market is witnessing unprecedented growth, driven by significant advances in sequencing technologies and heightened interest in personalized medicine. As bioinformatics continues to evolve, its impact on drug discovery and genomic research becomes increasingly profound.
Immunovant, a biotechnology company known for its innovative treatments for autoimmune diseases, has recently announced a significant shift in its development strategy. Despite late-stage successes with its experimental drug batoclimab, the company has decided to momentarily hold back on seeking
